Adamkov Marian, Výbohová Desanka, Tupá Veronika, Chylíková Jaroslava, Horáček Jaroslav, Benčat Marián
Comenius University Bratislava, Jessenius Faculty of Medicine in Martin, Department of Histology and Embryology, Malá Hora 4, 036 01 Martin, Slovakia.
Comenius University Bratislava, Jessenius Faculty of Medicine in Martin, Department of Anatomy, Malá Hora 4, 036 01 Martin, Slovakia.
Acta Histochem. 2015 Jul;117(6):590-4. doi: 10.1016/j.acthis.2015.05.006. Epub 2015 Jun 18.
We examined immunohistochemically the expression pattern of a potential tumor biomarker survivin in a panel of 116 tubular adenomatous polyps to determine its association with clinicomorphological parameters such as age of patients, size of polyps, degree of dysplasia and polyp localization. In each section, the subcellular localization of survivin antigen and the intensity of staining were assessed. Overall, survivin was expressed in 90 cases (77.6%). Cytoplasmic positivity was observed in 46/116 cases (39.7%), while nuclear and combined nuclear and cytoplasmic reaction in 44/116 cases (37.9%). High grade dysplasia was diagnosed in 52 cases (44.8%) and low grade dysplasia in 64 cases (55.2%). Statistical analysis revealed a significant correlation between subcellular survivin localization and the degree of dysplasia, size of polyps and colon localization. On the other hand, survivin expression pattern did not correlate with the age of patients. Statistically significant trend was confirmed between intensity of survivin immunoreaction and tumor size and dysplasia grade, and also the trend between negative/strong survivin intensity and polyp localization. Another statistically significant association was found between the degree of dysplasia and the size of polyps. Our findings revealed that survivin is frequently expressed in different subcellular compartments of adenoma cells. Our recent results suggest that the nuclear and combined nuclear and cytoplasmic survivin localizations are strongly associated with poor prognostic parameters in the assessment of colon adenomas. Thus, survivin may represent a promising biomarker in immunohistochemical evaluation of these lesions.
我们采用免疫组织化学方法检测了116例管状腺瘤性息肉中潜在肿瘤生物标志物生存素的表达模式,以确定其与患者年龄、息肉大小、发育异常程度及息肉定位等临床形态学参数的相关性。在每一个切片中,评估生存素抗原的亚细胞定位及染色强度。总体而言,生存素在90例(77.6%)中表达。在46/116例(39.7%)中观察到细胞质阳性,而在44/116例(37.9%)中观察到细胞核及细胞核与细胞质联合反应。52例(44.8%)诊断为高级别发育异常,64例(55.2%)为低级别发育异常。统计分析显示,生存素亚细胞定位与发育异常程度、息肉大小及结肠定位之间存在显著相关性。另一方面,生存素表达模式与患者年龄无关。生存素免疫反应强度与肿瘤大小及发育异常级别之间的统计学显著趋势得到证实,生存素阴性/强阳性强度与息肉定位之间的趋势也得到证实。发育异常程度与息肉大小之间还发现了另一个统计学显著关联。我们的研究结果显示,生存素在腺癌细胞的不同亚细胞区室中频繁表达。我们最近的结果表明,在结肠腺瘤评估中,细胞核及细胞核与细胞质联合生存素定位与不良预后参数密切相关。因此,在这些病变的免疫组织化学评估中,生存素可能是一个有前景的生物标志物。